JP2012524781A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012524781A5 JP2012524781A5 JP2012507248A JP2012507248A JP2012524781A5 JP 2012524781 A5 JP2012524781 A5 JP 2012524781A5 JP 2012507248 A JP2012507248 A JP 2012507248A JP 2012507248 A JP2012507248 A JP 2012507248A JP 2012524781 A5 JP2012524781 A5 JP 2012524781A5
- Authority
- JP
- Japan
- Prior art keywords
- selectin
- use according
- subject
- wound
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010052428 Wound Diseases 0.000 claims 15
- 208000027418 Wounds and injury Diseases 0.000 claims 15
- 102000015689 E-Selectin Human genes 0.000 claims 13
- 108010024212 E-Selectin Proteins 0.000 claims 13
- 239000003795 chemical substances by application Substances 0.000 claims 9
- 206010012601 diabetes mellitus Diseases 0.000 claims 9
- 102000039446 nucleic acids Human genes 0.000 claims 8
- 108020004707 nucleic acids Proteins 0.000 claims 8
- 150000007523 nucleic acids Chemical class 0.000 claims 8
- 210000000130 stem cell Anatomy 0.000 claims 8
- 210000001185 bone marrow Anatomy 0.000 claims 7
- 102000006573 Chemokine CXCL12 Human genes 0.000 claims 6
- 108010008951 Chemokine CXCL12 Proteins 0.000 claims 6
- 239000003814 drug Substances 0.000 claims 5
- 238000002639 hyperbaric oxygen therapy Methods 0.000 claims 4
- 239000003937 drug carrier Substances 0.000 claims 3
- 238000004519 manufacturing process Methods 0.000 claims 3
- 230000005012 migration Effects 0.000 claims 3
- 238000013508 migration Methods 0.000 claims 3
- 239000002245 particle Substances 0.000 claims 3
- 102000040430 polynucleotide Human genes 0.000 claims 3
- 108091033319 polynucleotide Proteins 0.000 claims 3
- 239000002157 polynucleotide Substances 0.000 claims 3
- 102000004169 proteins and genes Human genes 0.000 claims 3
- 108090000623 proteins and genes Proteins 0.000 claims 3
- 239000013603 viral vector Substances 0.000 claims 3
- 230000035876 healing Effects 0.000 claims 2
- 229940124597 therapeutic agent Drugs 0.000 claims 2
- 210000002845 virion Anatomy 0.000 claims 2
- 230000003612 virological effect Effects 0.000 claims 2
- 108090000565 Capsid Proteins Proteins 0.000 claims 1
- 102100023321 Ceruloplasmin Human genes 0.000 claims 1
- 102000003800 Selectins Human genes 0.000 claims 1
- 108090000184 Selectins Proteins 0.000 claims 1
- 230000003511 endothelial effect Effects 0.000 claims 1
- AAEVYOVXGOFMJO-UHFFFAOYSA-N prometryn Chemical compound CSC1=NC(NC(C)C)=NC(NC(C)C)=N1 AAEVYOVXGOFMJO-UHFFFAOYSA-N 0.000 claims 1
- 230000001737 promoting effect Effects 0.000 claims 1
- 239000013608 rAAV vector Substances 0.000 claims 1
- 230000029663 wound healing Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17127109P | 2009-04-21 | 2009-04-21 | |
| US61/171,271 | 2009-04-21 | ||
| PCT/US2010/030471 WO2010123699A2 (en) | 2009-04-21 | 2010-04-09 | Compositions, kits and methods for promoting ischemic and diabetic wound healing |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012524781A JP2012524781A (ja) | 2012-10-18 |
| JP2012524781A5 true JP2012524781A5 (https=) | 2013-05-30 |
Family
ID=43011688
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012507248A Pending JP2012524781A (ja) | 2009-04-21 | 2010-04-09 | 虚血性及び糖尿病性創傷の治癒を促進する組成物、キット及び方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20120058086A1 (https=) |
| EP (1) | EP2421967A4 (https=) |
| JP (1) | JP2012524781A (https=) |
| KR (1) | KR20120023633A (https=) |
| CN (1) | CN102421894A (https=) |
| WO (1) | WO2010123699A2 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2016516071A (ja) * | 2013-03-15 | 2016-06-02 | ユベンタス セラピューティクス，インコーポレイテッド | 瘢痕形成を軽減するためのｓｄｆ−１の使用 |
| EP3237622B1 (en) * | 2014-12-23 | 2021-02-24 | Ilya Pharma AB | Methods for wound healing |
| WO2016149632A1 (en) * | 2015-03-18 | 2016-09-22 | Bio1 Systems, Llc | Digital wound assessment device and method |
| CN106581068A (zh) * | 2016-11-08 | 2017-04-26 | 广州医科大学附属第三医院 | 一种可以快速恢复皮肤创面的生物膜及其制备方法 |
| CN110769861A (zh) * | 2017-05-02 | 2020-02-07 | 迈阿密大学 | 治疗缺血性组织的方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070244043A1 (en) * | 2005-03-10 | 2007-10-18 | Novavax, Inc. | Recombinant E-selectin made in insect cells |
| US8440617B2 (en) * | 2007-03-22 | 2013-05-14 | The Trustees Of The University Of Pennsylvania | Hyperbaric treatment in wound healing |
-
2010
- 2010-04-09 CN CN201080019437XA patent/CN102421894A/zh active Pending
- 2010-04-09 EP EP10767514A patent/EP2421967A4/en not_active Withdrawn
- 2010-04-09 KR KR1020117026193A patent/KR20120023633A/ko not_active Abandoned
- 2010-04-09 WO PCT/US2010/030471 patent/WO2010123699A2/en not_active Ceased
- 2010-04-09 JP JP2012507248A patent/JP2012524781A/ja active Pending
- 2010-04-09 US US13/138,889 patent/US20120058086A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Rajarshi et al. | Combating COVID-19 with mesenchymal stem cell therapy | |
| EP4378487A3 (en) | Modified factor ix, and compositions, methods and uses for gene transfer to cells, organs and tissues | |
| JP2012524781A5 (https=) | ||
| JP2018537984A5 (https=) | ||
| BR112021023692A2 (pt) | Partícula viral de vírus adeno-associado recombinante, proteína de capsídeo de vírus adeno-associado, molécula de ácido nucleico, célula empacotadora, métodos de produção de uma partícula viral e de distribuição de um nucleotídeo, e, composição farmacêutica | |
| RU2014142267A (ru) | Лекарственное средство для лечения острого миелоидного лейкоза (омл) | |
| JP2009545310A5 (https=) | ||
| Canham et al. | The use of mesenchymal stromal cells in the treatment of coronavirus disease 2019 | |
| CN107137700B (zh) | 一种基于干细胞源外泌体的组合物及其在制备治疗心肌梗死的药物中的应用 | |
| WO2013126590A3 (en) | Pharmaceutical composition comprising cd34+ cells | |
| JP2012518646A5 (https=) | ||
| Jing | Exploration on the feasibility of moxibustion in prevention and treatment of COVID-19 from the perspective of modern medical mechanism | |
| CN103565876A (zh) | 一种药艾条及其用途 | |
| JP2020518644A5 (https=) | ||
| AU2018261420A1 (en) | Method for treating ischemic tissue | |
| JP2012524781A (ja) | 虚血性及び糖尿病性創傷の治癒を促進する組成物、キット及び方法 | |
| JPWO2022018729A5 (https=) | ||
| JP2009538935A5 (https=) | ||
| CN111437293A (zh) | 蟾酥提取物在制备治疗SARS-CoV-2病毒引起的感染性疾病的药物中的应用 | |
| Lee | Growth factors in oral and maxillofacial surgery: potentials and challenges | |
| Guo et al. | Combination of metronidazole and pearl powders for the treatment of stage 2 pressure injury wounds: Case report and literature review | |
| ZA202304877B (en) | Recombinant adeno-associated viruses with enhanced liver tropism and uses thereof | |
| JP2014501242A5 (https=) | ||
| Jiao et al. | Metal-organic framework-based nanoplatform enhance fibroblast activity to treat periodontitis | |
| CN106727609A (zh) | 一种治疗病毒性心肌炎的药物组合物 |